The briefing
Researchers at RCSI report a new anticancer vaccine approach targeting neuroblastoma, indicating promising immune responses in early findings. The work outlines a potential path for future pediatric cancer immunotherapies pending further validation.
Original headline
Anticancer Vaccine Breakthrough Targets Neuroblastoma